Showing 114 of 114on this page. Filters & sort apply to loaded results; URL updates for sharing.114 of 114 on this page
Kallyope Announces 2026 Strategic Priorities for Migraine and ...
Kallyope Announces a $66M Series B to Develop Drugs Targeting Gut-Brain ...
Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of ...
Kallyope IPO: Investment Opportunities & Pre-IPO Valuations - Forge
Kallyope | LinkedIn
Kallyope K-645-P003 - Apps on Google Play
Working at Kallyope | Glassdoor
Kallyope - 2026 Funding Rounds & List of Investors - Tracxn
Kallyope by FluidGirl82 on DeviantArt
Kallyope
Kallyope Raises Another $112M to Map Out the Gut-Brain Axis to Develop ...
Kallyope Receives $8.3M from the Gates Foundation to Identify Novel ...
#columbiabusinessschool #entrepreneurship | Kallyope
KALLYOPE – Funding, Valuation, Investors, News
Kallyope Enters Phase 2 With First-in-class Oral Approach for the ...
Kallyope Advances Migraine and Metabolic Therapies with Klarity ...
Kallyope | The Org
Episode 6: Biological Cartography; How Kallyope is Mapping the Gut ...
BARREL | Project Roundup: Kallyope and Columbia College Core to ...
The Kallyope Yell — Jonathan David
Kallyope Raises $66 Million for Gut-Brain Axis Drug and Platform ...
Kallyope's Groundbreaking Research on Neural Networks | Kallyope posted ...
Kallyope progresses to Phase 2, pioneering an oral treatment strategy ...
Kallyope heads to Phase 3 with migraine drug after mid-stage success
Kallyope quietly reports Phase 2 obesity data, begins mid-stage ...
#jpm26 #jpm2026 | Kallyope
#liftingtheburden #ihw | Kallyope
Kallyope Receives $8.2 Million Grant from Gates Foundation | citybiz
Kallyope Presents Elismetrep Results at AAN Annual Meeting | The Column ...
Kallyope Employee Perks & Benefits | Levels.fyi
Kallyope Is Digesting Gut–Brain Biology into Medicines - Jonathan D ...
Grupo Cooprofar - KALLYOPE E NOVO NORDISK ANUNCIAM COLABORAÇÃO PARA ...
#didyouknow #type2diabetes #gutbrainaxis #drugdevelopment | Kallyope
Simon Mathieu - Medicinal Chemist at Kallyope | The Org
Panel on obesity treatments at LifeSciences | Kallyope posted on the ...
Kallyope on LinkedIn: H1 2022 New York Healthcare Funding Midyear ...
Kallyope Design - El color es un medio para ejercer... | Facebook
Xiang-Qing Li - Senior Research Associate at Kallyope | The Org
Pin on Kallyope Crawford
Kallyope Discreetly Drops Disappointing Data for Oral Obesity Candidate ...
Birra artigianale KALLYOPE - BLONDE ALE con zenzero, luppoli e malti ...
Biotech startup Kallyope raises $66M to study the gut-brain connection ...
Kallyope on LinkedIn: GETHEADUCATED™ Initiative Launches During MHAM ...
Kallyope Patents - Insights & Stats
Interviewing the Brightest Minds: With Jay Galeota | Kallyope
Kallyope and Novo Nordisk Announce Collaboration to Discover Novel ...
Kallyope Inc. Appoints Brett Lauring As Chief Medical Officer
Kallyope Presents New Data on Novel TRPM8 Channel Blocker Elismetrep ...
Paul Muller - Scientist II at Kallyope | The Org
Michael Luzung on LinkedIn: #teamwork #kallyope #biotech #spartan
These are the 10 NYC Startups That Raised the Most Amount of Capital in ...
Kallyope's focus on the gut-brain axis yields diverse portfolio
Top 17 Pharmaceutical Unicorns in 2024
《Cell》为什么紧张就跑厕所？Kallyope团队揭示肠神经元调控胃肠功能与炎症机制_腾讯新闻
Top 232 medical and healthcare startups in New York
Eachof these verticals required a different type of analysis:
Kallyope’s Phase 2b Study of Elismetrep, A Novel Approach for Treating ...
Kallyopë | Oukonva
Migraine Treatment Fails 70% of Patients, Kallyope's Elismetrep Offers ...
The 20 Largest NYC Tech Startup Funding Rounds of 2022 – AlleyWatch
融资总额超2.4亿美元，Kallyope专注开发肠-脑轴机制新药-动脉网
Kallyope-Kallyope Inc.-企业详情-InvestGO数据库-ByDrug-医药魔方数据库
#drugdiscovery #collaboration #gpcr #gastrointestinaldisease | Nxera Pharma
Lux Capital
Exploring Alternative Funding Options for Biotechnology Startups
#kallyope #ens #cellsymposia #neurometabolism | Paul Muller
Klarity - Built Therapeutic Platform Technologies for Metabolism ...
Ann Weber posted on LinkedIn
The 2026 American Academy of Neurology (AAN) Annual Meeting is next ...
Novo acquires three early-stage obesity programs from Columbia-linked ...
'장-뇌 축' 전문 Kallyope, 시리즈B 6600만弗 확보 - 바이오스펙테이터
Karkara + Kallyopë - Le Fotomat'
Kallyope偏頭痛新藥艾利美特普二期b研究數據公布 療效顯著擬啟動註冊性試驗
When and why should you take on roles where there are no defined job ...
专利分析｜AMPK激活剂如何靶向肠道？_财富号_东方财富网
Kallyope, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Nancy Thornberry - Biocom
Pharma News | Kallyope, IDEAYA Biosciences, Ayrmid
About us | Outsourced HR Solutions | 1130 Works
治疗肥胖、糖尿病等多种疾病，2.36亿美元助力开发肠-脑轴创新疗法 药明康德 内容团队编辑2022年2月15日，Kallyope公司宣布完成2 ...
Host Companies | Project Onramp
Cision - MediaStudio View Media
生物技术公司Kallyope完成2100万美元B轮融资，开发“内脏-大脑轴”生物学疗法-动脉网
Veeva Basics
How do AMPK activators target the intestines?
%2C+and+Genentech.)
